select trial semaglutide nejm New in the May 29, 2025, issue of NEJM: Sotatercept in Pulmonary Arterial Hypertension (ZENITH phase 3 trial) https://nej.md/4iYkLbj Oral and Cardiovascular Outcomes (SOUL trial) https://nej.md/4hHII5M Upadacitinib for Giant-Cell Arteritis Orforglipron, an Oral Small-Molecule GLP-1

By enhancing satiety through increased endogenous GLP-1, CCK, and PYY while reducing ghrelin levels, these polyols may help consumers limit caloric intake and manage their weight more effective 3

What To Know Novo Nordisk also said in its announcement on Monday that for existing self-pay patients using the injections, costs will also be slashed

While your belly may slim down, so might your buttocks and face

This condition often affects people who have obesity or Type 2 diabetes

For many years, society has labeled weight gain as a symptom of overindulgence or a sedentary life

Additionally, patients with diabetic kidney disease or on certain blood pressure medications should work closely with providers to monitor kidney function and electrolytes